In the midst of a mental health crisis, the world is in need of better alternatives for healing.

MindCure is the company bringing mental wealth to mental health care, with a complete cycle of wellness from psychedelic research to remedy.

MindCure ties together a team of world-renowned scientific leaders, psychedelic experts, and technology developers to create an all-new paradigm of mental health care

for both clinicians and their clients.

MindCure's research aims to bring solutions to market for under-researched indications.

We've developed an exclusive research project focused on female sexual desire and are

underway of our production of synthetic ibogene to be used in the development of solutions

for addiction, neuropathic pain, and migraines.

We're also the company behind iStream, a proprietary software with adaptive, AI-backed features.

Learn more about our innovative work, including the Desire Project, Ibegain production, and

iStream by visiting MindCure.com.

Hey, everybody, Joe Moore here.

Welcome back to psychedelics today.

I'm coming at you from Breckermich, Colorado.

Today on the show, we have the hosts of a podcast called Entheogen Show.

They've been around for a while and we've been

trying to get together for ages actually to do a podcast and we finally were able to pull it off.

These folks have been around for a while and I think there's some good conversation here,

good analysis of what's going on in the scene, where we've come from,

and where we're going in the psychedelic scene. So I think you're going to like it. And,

you know, I'm really curious what you think. Uh, so let us know what you think by emailing us

or hitting us up on socials info at psychedelics today.com. We'd love to hear it. I definitely want to read what you think about

...